# Levothyroxine sodium

NDC: 68788-7969
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210728

FDA application: ANDA212399

## Active ingredients

- LEVOTHYROXINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-7969"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-7969
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=633b3f9c-9578-4e07-a515-aec1a8b65e92